JPH09506635A - インターロイキン−6の生産を阻害するステファニアテトランドラの抽出物 - Google Patents
インターロイキン−6の生産を阻害するステファニアテトランドラの抽出物Info
- Publication number
- JPH09506635A JPH09506635A JP8500687A JP50068796A JPH09506635A JP H09506635 A JPH09506635 A JP H09506635A JP 8500687 A JP8500687 A JP 8500687A JP 50068796 A JP50068796 A JP 50068796A JP H09506635 A JPH09506635 A JP H09506635A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- tetrandra
- hours
- moore
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1994-12962 | 1994-06-09 | ||
KR19940012962 | 1994-06-09 | ||
PCT/KR1995/000073 WO1995033473A1 (en) | 1994-06-09 | 1995-06-05 | Extracts of stephania tetrandra for inhibition of interleukin-6 production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09506635A true JPH09506635A (ja) | 1997-06-30 |
Family
ID=19384977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8500687A Pending JPH09506635A (ja) | 1994-06-09 | 1995-06-05 | インターロイキン−6の生産を阻害するステファニアテトランドラの抽出物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0759766A1 (zh) |
JP (1) | JPH09506635A (zh) |
KR (1) | KR0161145B1 (zh) |
CN (1) | CN1150389A (zh) |
WO (1) | WO1995033473A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038693A1 (fr) * | 1998-12-25 | 2000-07-06 | Toray Industries, Inc. | Inhibiteurs de la production d'interleukine-6 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09253208A (ja) * | 1996-03-21 | 1997-09-30 | Unisia Jecs Corp | 鼻腔用投薬器 |
US6162437A (en) * | 1997-11-25 | 2000-12-19 | Korea Institute Of Science & Technology | Method for inhibiting interleukin-6 production by administering extracts from root of Stephania tetrandra |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04159278A (ja) * | 1990-10-24 | 1992-06-02 | Tsumura & Co | 新規アルカロイドおよび該アルカロイドを有効成分とするアセチルコリンエステラーゼ阻害剤 |
-
1995
- 1995-05-12 KR KR1019950011641A patent/KR0161145B1/ko not_active IP Right Cessation
- 1995-06-05 CN CN95193509A patent/CN1150389A/zh active Pending
- 1995-06-05 WO PCT/KR1995/000073 patent/WO1995033473A1/en not_active Application Discontinuation
- 1995-06-05 EP EP95922772A patent/EP0759766A1/en not_active Ceased
- 1995-06-05 JP JP8500687A patent/JPH09506635A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038693A1 (fr) * | 1998-12-25 | 2000-07-06 | Toray Industries, Inc. | Inhibiteurs de la production d'interleukine-6 |
Also Published As
Publication number | Publication date |
---|---|
KR960000242A (ko) | 1996-01-25 |
EP0759766A1 (en) | 1997-03-05 |
KR0161145B1 (ko) | 1998-12-01 |
CN1150389A (zh) | 1997-05-21 |
WO1995033473A1 (en) | 1995-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009212969B2 (en) | A composition for treating neurocerebrovascular disorders | |
JP4988988B2 (ja) | Il−13およびil−13レセプター鎖の拮抗による線維症の処置 | |
EP1931366B1 (en) | Herbal composition for inflammatory disorders | |
KR101487935B1 (ko) | 곰보배추의 추출물 또는 이의 분획물을 유효성분으로 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물 | |
US6030980A (en) | Agent for the treatment of infections | |
US6991814B2 (en) | Herbal medicaments for the treatment of neurocerebrovascular disorders | |
KR101577792B1 (ko) | 마치현 추출물 또는 이의 분획물을 유효성분으로 포함하는 il-6 매개성 질환의 예방 또는 치료용 약학적 조성물 | |
JPH10501549A (ja) | アカント酸の製造方法およびこれを含む医薬組成物 | |
JPH11500119A (ja) | インターロイキン12を用いる脈管形成の阻害 | |
KR101673265B1 (ko) | 개머루덩굴 추출물, 이의 분획물 또는 이로부터 분리된 화합물을 유효성분으로 포함하는 il-6 매개성 질환의 예방 또는 치료용 약학적 조성물 | |
Kang et al. | Anti‐inflammatory effects of Stephania tetrandra S. Moore on interleukin‐6 production and experimental inflammatory disease models | |
JPH09506635A (ja) | インターロイキン−6の生産を阻害するステファニアテトランドラの抽出物 | |
ES2426174T3 (es) | Composición herbácea para trastornos inflamatorios | |
US6162437A (en) | Method for inhibiting interleukin-6 production by administering extracts from root of Stephania tetrandra | |
US5616325A (en) | Stimulator of vascular endothelial cells and use thereof | |
KR101606645B1 (ko) | 다우리놀 화합물을 유효성분으로 포함하는 면역질환의 예방 및 치료용 조성물 | |
KR102506076B1 (ko) | 황산아연, 락토바실러스 애시도필러스 및 코엔자임 q를 포함하는 면역질환의 예방 또는 치료용 조성물 | |
KR100541248B1 (ko) | 암전이 억제효과를 갖는 장생도라지 추출물 | |
KR20030002972A (ko) | 항염증 활성 및 항동맥경화 활성을 나타내는 틸리아닌 | |
KR20220168960A (ko) | 감초 신품종 원감 또는 신원감을 포함하는 알레르기에 치료 및 예방에 효과있는 약제학적 조성물 및 그 치료제 | |
CN109730990A (zh) | 15-苄亚基-14-脱氧-11,12-脱氢穿心莲内酯衍生物在抗纤维化药物中的应用 | |
CN113230255A (zh) | 阿帕替尼在制备防治nlrp3炎症小体相关疾病的药物中的应用 | |
MX2008004291A (es) | Composicion herbaria para trastornos inflamatorios | |
KR20160018984A (ko) | 센티페드그라스 추출물을 유효성분으로 함유하는 골 질환 예방 및 치료용 약학적 조성물 |